Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16 INK4a

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2969-2975

  Wu, Dan Sen ^a   Shen, Jian Zhen ^a   Yu, Ai Fang ^a   Fu, Hai Ying ^a   Zhou, Hua Rong ^a   Shen, Song Fei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

CA46 cells; Epigallocatechin 3 gallate; Epigenetics; Methylation; P16INK4a gene; Trichostatin A

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIGALLOCATECHIN GALLATE; TRICHOSTATIN A;

ARTICLE; BURKITT LYMPHOMA; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA METHYLATION; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA CELL; P16INK4A GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DRUG SYNERGISM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; LYMPHOMA; PROMOTER REGIONS, GENETIC;

EID: 84892407047     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2734     Document Type: Article

References (35)

1. Li G, Ji Y, Liu C, Li J and Zhou Y: Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma. Mol Med Rep 5: 1106-1110, 2012.
2. Herman JG, Merlo A, Mao L, et al: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995.
3. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
4. INK4a inhibits cancer cell growth by down-regulating eEF1A2 through a direct interaction. J Cell Sci 126: 1744-1752, 2013.
5. Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res 70: 9381-9390, 2010.
6. Fang K, Chiu CC, Li CH, Chang YT and Hwang HT: Cisplatin-induced senescence and growth inhibition in human non-small cell lung cancer cells with ectopic transfer of p16INK4a. Oncol Res 16: 479-488, 2007.
7. INK4a hypermethylation in plasma by real-time PCR. Korean J Pathol 46: 554-561, 2012.
8. Ameri A, Alidoosti A, Hosseini SY, et al: Prognostic value of promoter hypermethylation of retinoic acid receptor beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer. Chin J Cancer Res 23: 306-311, 2011.
9. Zhu Z, Wang Y, Liu Z, Wang F and Zhao Q: Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1. Oncol Rep 27: 1567-1572, 2012.
10. INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32: 537-544, 2011.
11. INK4A expression. Nucleic Acids Res 40: 981-995, 2012.
12. Zanders ED: Overview of chemical genomics and proteomics. Methods Mol Biol 800: 3-10, 2012.
13. Sandoval J and Esteller M: Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22: 50-55, 2012.
14. Palmisano WA, Divine KK, Saccomanno G, et al: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958, 2000.
15. Choung HK, Kim YA, Lee MJ, Kim N and Khwarg SI: Multigene methylation analysis of ocular adnexal MALT lymphoma and their relationship to Chlamydophila psittaci infection and clinical characteristics in South Korea. Invest Ophthalmol Vis Sci 53: 1928-1935, 2012.
16. INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma. Leukemia Res 35: 438-443, 2011.
17. Sato H, Oka T, Shinnou Y, et al: Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am J Pathol 176: 402-415, 2010.
18. Kondo T, Oka T, Sato H, et al: Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. Int J Oncol 35: 547-557, 2009.
19. Kim SO and Kim MR: (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC 1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol 42: 349-358, 2013.
20. Rajarajacholan UK, Thalappilly S and Riabowol K: The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. PLoS Biol 11: e1001502, 2013.
21. Nakagawa H, Hasumi K, Woo JT, Nagai K and Wachi M: Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 25: 1567-1574, 2004.
22. Satoh A, Toyota M, Itoh F, et al: DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer 86: 1817-1823, 2002.
23. Steele N, Finn P, Brown R and Plumb JA: Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Br J Cancer 100: 758-763, 2009.
24. Dannenberg LO and Edenberg HJ: Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 7: 181, 2006.
25. Oh HJ, Lee TH, Lee JH and Lee BC: Trichostatin A improves preimplantation development of bovine cloned embryos and alters expression of epigenetic and pluripotency genes in cloned blastocysts. J Vet Med Sci 74: 1409-1415, 2012.
26. Wu X, Li Y, Li GP, et al: Trichostatin A improved epigenetic modifications of transfected cells but did not improve subsequent cloned embryo development. Anim Biotechnol 19: 211-224, 2008.
27. Klisovic MI, Maghraby EA, Parthun MR, et al: Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells. Leukemia 17: 350-358, 2003.
28. Shaker S, Bernstein M, Momparler LF and Momparler RL: Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk Res 27: 437-444, 2003.
29. Beltz LA, Bayer DK, Moss AL and Simet IM: Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 6: 389-406, 2006.
30. Navarro-Martínez MD, García-Cánovas F and Rodríguez-López JN: Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J Antimicrob Chemother 57: 1083-1092, 2006.
31. Fang M, Chen D and Yang CS: Dietary polyphenols may affect DNA methylation. J Nutr 137: 223S-228S, 2007.
32. Fang MZ, Wang Y, Ai N, et al: Tea polyphenol (-)-epigallo-catechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570, 2003.
33. Li Y and Tollefsbol TO: Impact on DNA methylation in cancer prevention and treatment by bioactive dietary components. Curr Med Chem 17: 2141-2151, 2010.
34. Lee WJ, Shim JY and Zhu BT: Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68: 1018-1030, 2005.
35. Peurala E, Koivunen P, Haapasaari KM, Bloigu R and Jukkola-Vuorinen A: The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. Breast Cancer Res 15: R5, 2013.